10-Q Filing

Processa Pharmaceuticals, Inc. CIK: 1533743 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001493152-22-022063`
Period End Date	20220630
Filing Date	20220811
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 50 Cash Flow Statement 62 Stockholders Equity 26

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.50M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	15.71M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	15.92M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.06M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	15.71M	shares	Point-in-time
Due from tax agencies	`DueFromTaxAgencies`	-	USD	Point-in-time
Due from tax agencies	`DueFromTaxAgencies`	$70.27K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	15.82M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.76M	USD	Point-in-time
Treasury stock shares	`TreasuryStockShares`	100,000.00	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.90M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$13.96M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$18.33M	USD	Point-in-time
Property and Equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Property and Equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Operating lease right-of-use assets, net of accumulated amortization	`OperatingLeaseRightOfUseAsset`	$28.89K	USD	Point-in-time
Operating lease right-of-use assets, net of accumulated amortization	`OperatingLeaseRightOfUseAsset`	$74.18K	USD	Point-in-time
Intangible assets, net of accumulated amortization	`IntangibleAssetsNetExcludingGoodwill`	$7.66M	USD	Point-in-time
Intangible assets, net of accumulated amortization	`IntangibleAssetsNetExcludingGoodwill`	$8.06M	USD	Point-in-time
Security deposit	`SecurityDeposit`	$5.54K	USD	Point-in-time
Security deposit	`SecurityDeposit`	$5.54K	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$8.14M	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$7.70M	USD	Point-in-time
Total Assets	`Assets`	$26.46M	USD	Point-in-time
Total Assets	`Assets`	$21.66M	USD	Point-in-time
Current maturities of operating lease liability	`OperatingLeaseLiabilityCurrent`	$71.08K	USD	Point-in-time
Current maturities of operating lease liability	`OperatingLeaseLiabilityCurrent`	$26.55K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$218.91K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$648.10K	USD	Point-in-time
Due to licensor	`DueToLicensor`	$400.00K	USD	Point-in-time
Due to licensor	`DueToLicensor`	$589.00K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$1.77K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$279.26K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$307.41K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.57M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$971.02K	USD	Point-in-time
Non-current operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$7.38K	USD	Point-in-time
Non-current operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$4.66K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.58M	USD	Point-in-time
Total Liabilities	`Liabilities`	$978.40K	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value $0.0001, 50,000,000 shares authorized: 15,919,317 issued and 15,819,317 outstanding at June 30, 2022, and 15,710,246 issued and outstanding at December 31, 2021	`CommonStockValue`	$1.57K	USD	Point-in-time
Common stock, par value $0.0001, 50,000,000 shares authorized: 15,919,317 issued and 15,819,317 outstanding at June 30, 2022, and 15,710,246 issued and outstanding at December 31, 2021	`CommonStockValue`	$1.59K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$62.31M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$65.60M	USD	Point-in-time
Treasury stock at cost 100,000 shares at June 30, 2022	`TreasuryStockValue`	$300.00K	USD	Point-in-time
Treasury stock at cost 100,000 shares at June 30, 2022	`TreasuryStockValue`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-36.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-45.21M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$23.24M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$25.49M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$22.94M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$29.24M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$20.08M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$31.34M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$21.66M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$26.46M	USD	Point-in-time

Income Statement 50 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$5.18M	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.61M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$3.09M	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$3.14M	USD	1 Quarter
Acquisition of in-process research and development	`ResearchAndDevelopmentInProcess`	-	USD	2 Qtrs
Acquisition of in-process research and development	`ResearchAndDevelopmentInProcess`	$515.63K	USD	1 Quarter
Acquisition of in-process research and development	`ResearchAndDevelopmentInProcess`	-	USD	1 Quarter
Acquisition of in-process research and development	`ResearchAndDevelopmentInProcess`	$515.63K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.03M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.22M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.33M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.05M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-5.17M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-3.46M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-5.65M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-8.40M	USD	2 Qtrs
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPayrollProtectionProgramLoanAndRelatedAccruedInterest`	$163.77K	USD	1 Quarter
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPayrollProtectionProgramLoanAndRelatedAccruedInterest`	-	USD	2 Qtrs
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPayrollProtectionProgramLoanAndRelatedAccruedInterest`	-	USD	1 Quarter
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPayrollProtectionProgramLoanAndRelatedAccruedInterest`	$163.77K	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	2 Qtrs
Interest expense	`InterestExpense`	$362.00	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$6.75K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$8.96K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.81K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$7.38K	USD	1 Quarter
Net Operating Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.29M	USD	1 Quarter
Net Operating Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.48M	USD	2 Qtrs
Net Operating Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.39M	USD	2 Qtrs
Net Operating Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.16M	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-137.17K	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-226.42K	USD	2 Qtrs
Income Tax Benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-8.39M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-3.16M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-5.26M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-3.23M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-5.16M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.10M	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasic`	$-0.53	USD	2 Qtrs
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasic`	$-0.35	USD	2 Qtrs
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasic`	$-0.20	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasic`	$-0.32	USD	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	15.94M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	15.89M	shares	2 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	15.41M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	15.00M	shares	2 Qtrs

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.39M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.26M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.23M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.10M	USD	1 Quarter
Depreciation	`Depreciation`	-	USD	2 Qtrs
Depreciation	`Depreciation`	$484.00	USD	2 Qtrs
Non-cash lease expense for right-of-use assets	`OperatingLeaseExpense`	$45.29K	USD	2 Qtrs
Non-cash lease expense for right-of-use assets	`OperatingLeaseExpense`	$41.32K	USD	2 Qtrs
Non-cash milestone expense in connection with license agreement	`NoncashMilestoneExpenseInConnectionWithLicenseAgreement`	-	USD	2 Qtrs
Non-cash milestone expense in connection with license agreement	`NoncashMilestoneExpenseInConnectionWithLicenseAgreement`	$189.00K	USD	2 Qtrs
Non-cash acquisition of in-process research and development	`NonCashAcquisitionOfInprocessResearchAndDevelopment`	-	USD	2 Qtrs
Non-cash acquisition of in-process research and development	`NonCashAcquisitionOfInprocessResearchAndDevelopment`	$300.00K	USD	2 Qtrs
Amortization of issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$40.61K	USD	2 Qtrs
Amortization of issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	-	USD	2 Qtrs
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	$394.25K	USD	2 Qtrs
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	$397.66K	USD	2 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-226.42K	USD	2 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.17M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$2.84M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$2.01M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$865.32K	USD	1 Quarter
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest`	$163.77K	USD	2 Qtrs
Forgiveness of PPP loan and related accrued interest	`ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest`	-	USD	2 Qtrs
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-272.05K	USD	2 Qtrs
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$876.90K	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-47.26K	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-42.32K	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$362.00	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	-	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$429.20K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-32.82K	USD	2 Qtrs
Due (from) to related parties	`IncreaseDecreaseInDueToRelatedParties`	$-1.77K	USD	2 Qtrs
Due (from) to related parties	`IncreaseDecreaseInDueToRelatedParties`	$96.61K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-70.27K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-6.75K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$28.15K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$144.43K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.44M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.13M	USD	2 Qtrs
Net proceeds from private placement	`ProceedsFromIssuanceOfPrivatePlacement`	-	USD	2 Qtrs
Net proceeds from private placement	`ProceedsFromIssuanceOfPrivatePlacement`	$9.88M	USD	2 Qtrs
Acquisition of treasury stock	`ProceedsFromRepurchaseOfEquity`	$-300.00K	USD	2 Qtrs
Acquisition of treasury stock	`ProceedsFromRepurchaseOfEquity`	-	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-23.09K	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-300.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.85M	USD	2 Qtrs
Net Increase (Decrease) in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.43M	USD	2 Qtrs
Net Increase (Decrease) in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$5.41M	USD	2 Qtrs
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$20.83M	USD	Point-in-time
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.42M	USD	Point-in-time
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$16.50M	USD	Point-in-time
Cash and Cash Equivalents Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$12.06M	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$20.83M	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.42M	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$16.50M	USD	Point-in-time
Cash and Cash Equivalents End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$12.06M	USD	Point-in-time
Issuance of 123,609 shares of common stock in connection with the Purchase Agreement with Lincoln Park	`StockIssued1`	-	USD	2 Qtrs
Issuance of 123,609 shares of common stock in connection with the Purchase Agreement with Lincoln Park	`StockIssued1`	$450.00K	USD	2 Qtrs

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$23.24M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$25.49M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$22.94M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$29.24M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$20.08M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$31.34M	USD	Point-in-time
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$828.90K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$620.59K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$762.60K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.01M	USD	1 Quarter
Shares issued in private placement, net of transaction costs	`StockIssuedDuringPeriodValueNewIssues`	$9.88M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.39M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.26M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.23M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.10M	USD	1 Quarter
Shares issued in connection with license agreement	`StockIssuedDuringPeriodValueOther`	$300.00K	USD	1 Quarter
Acquisition of treasury stock	`StockRepurchasedDuringPeriodValue`	$300.00K	USD	1 Quarter
Shares issued in connection with the Purchase Agreement with Lincoln Park	`SharesIssuedInConnectionWithPurchaseAgreementValue`	$450.00K	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$23.24M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$25.49M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$22.94M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$29.24M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$20.08M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$31.34M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.